论文部分内容阅读
本文论证了“药品单独核算”方案的利弊得失、动力阻力以及实施的前提条件。
This article demonstrates the pros and cons of the “drug separate accounting” program gains and losses, dynamic resistance and the implementation of the prerequisites.